NCT00002135已完成不适用
An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
To provide oral ganciclovir to patients who require maintenance for control of cytomegalovirus (CMV) retinitis, but who lack patent permanent central venous access for long-term administration of intravenous drugs.
详细描述
Patients receive oral ganciclovir as maintenance. Patients enrolled at time of closure of enrollment will receive 2 months of study drug and undergo follow-up.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 13 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must have:
- •Stable CMV retinitis.
- •Treatment with IV ganciclovir or IV foscarnet for at least 18 of the past 21 days.
- •No permanent central IV catheter at present.
- •Had a permanent central IV catheter removed two or more times within the past 6 months due to catheter infection or thrombosis.
- •Consent of guardian if less than legal age of consent.
排除标准
- •Co-existing Condition:
- •Patients with the following symptoms or conditions are excluded:
- •Require continuation of concomitant medications precluded by this protocol.
- •Concurrent Medication:
- •Intravitreal anti-CMV treatment.
- •Any other concomitant medications precluded by the protocol.
- •Patients with the following prior condition are excluded:
- •History of hypersensitivity to acyclovir or ganciclovir.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus RetinitisCytomegalovirus RetinitisHIV InfectionsNCT00002134Roche Global Development450
已完成
2 期
The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIVCytomegalovirus RetinitisGastrointestinal DiseasesHIV InfectionsNCT00001034National Institute of Allergy and Infectious Diseases (NIAID)850
已完成
不适用
A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency VirusCytomegalovirus InfectionsHIV InfectionsNCT00002095Hoffmann-La Roche700
已完成
不适用
A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDSCytomegalovirus RetinitisHIV InfectionsNCT00002222Hoffmann-La Roche200
进行中（未招募）
2 期
Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant RecipientsCytomegalovirus InfectionsTransplant-Related DisorderNCT06066957University of Pennsylvania80